Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 29, 2020Cancer ResearchOpen Access

Lipopolysaccharide-Mediated Chronic Inflammation Promotes Tobacco Carcinogen–Induced Lung Cancer and Determines the Efficacy of Immunotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

CLChia‐Hsin LiuTri-Service General HospitalZCZhong ChenFuzhou Second HospitalKCKong ChenUniversity of Pittsburgh

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Liu et al. (2020) studied this question.

synapsesocial.com/papers/6a1c30f41567d2fc4d5fbce7https://doi.org/10.1158/0008-5472.can-20-1994
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1K-ras mutations in lung tumors from A/J and A/J×TSG-p53 F1 mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and phenethyl isothiocyanate1995 · 55 citations
  2. 2Comprehensive molecular profiling of lung adenocarcinoma2014 · 5,984 citations
  3. 3Impaired Tumor-Infiltrating T Cells in Patients with Chronic Obstructive Pulmonary Disease Impact Lung Cancer Response to PD-1 Blockade2018 · 104 citations
  4. 4T helper 17 cells play a critical pathogenic role in lung cancer2014 · 327 citations
  5. 5Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer2015 · 8,648 citations